End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9851 USD | -16.50% | -19.25% | -47.88% |
Chart calendar Notable Labs, Ltd.
Upcoming events on Notable Labs, Ltd.
No events available
Past events on Notable Labs, Ltd.
2024-04-12 08:00 am | Q4 2023 Earnings Release |
2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No:5178 |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No:2548 |
2023-05-15 04:01 pm | Q1 2023 Earnings Release |
2023-03-14 08:00 am | Q4 2022 Earnings Release |
2023-02-23 08:30 am | Vascular Biogenics Ltd. and Notable Labs Merger Call |
2022-11-14 04:05 pm | Q3 2022 Earnings Release |
2022-08-15 04:05 pm | Interim 2022 Earnings Release |
2022-06-08 03:00 pm | Jefferies Healthcare Conference |
2022-06-02 | American Society of Clinical Oncology Meeting |
2022-05-22 | H.C. Wainwright Global Life Sciences Investment Conference |
2022-05-17 08:30 am | Q1 2022 Earnings Call |
2022-05-17 07:00 am | Q1 2022 Earnings Release |
2022-05-12 02:30 am | Biomed Israel Conference |
2022-05-11 01:00 pm | LifeSci Partners Immunology & Inflammation Symposium |
2022-05-08 05:30 pm | IMMUNOLGY Meeting |
2022-04-11 12:00 pm | Investor Meeting - KOL |
2022-03-23 08:30 am | FY 2021 Earnings Call |
2022-03-23 07:00 am | FY 2021 Earnings Release |
2022-03-16 08:40 am | Oppenheimer Healthcare Conference |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,31 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -14,7 -14,5 -1.03% | -16,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -11,3 -14,5 22.33% | -16,8 |
Net income Million USD | Released Forecast Spread | -14,4 | -11,3 -14,5 22.33% | -14,5 |
EPS USD | Released Forecast Spread | -1,38 | -3,41 -1,62 -110.49% | -1,50 |
Announcement Date | 01/09/23 | 11/04/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,12 0,00 - | 0,19 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -1,75 -3,71 52.78% | -4,40 -3,88 -13.48% | |||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,89 -3,71 178.06% | -4,45 -3,87 -14.9% | |||||
Net income Million USD | Released Forecast Spread | 2,89 -3,71 178.06% | -4,45 -3,87 -14.9% | |||||
EPS USD | Released Forecast Spread | 0,19 -0,41 146.34% | -2,97 -0,43 -590.7% | -0,39 | -0,43 | -0,52 | -0,56 | -0,60 |
Announcement Date | 29/11/23 | 11/04/24 | - | - | - | - | - |
Past sector events for Notable Labs, Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NTBL Stock
- Calendar Notable Labs, Ltd.